Proliferation studies showed that, in breast cancer cells treated with this STS inhibitor, the DNA synthesis decreased by a modest 20%, and the estradiol concentration decreased by 26%, suggesting the treatment with STS inhibitors alone was not sufficient to block cancer cells growth [19]. Here, STS is linked to breast carcinoma.